Skip to main content
    • Aa
    • Aa

Antipsychotics for BPSD: an audit of prescribing practice in a specialist psychiatric inpatient unit

  • Camilla Haw (a1), Jean Stubbs (a1) and Graeme Yorston (a1)

Background: Antipsychotics are widely used for the treatment of behavioral and psychological symptoms of dementia (BPSD). In the light of the increased risk of cerebrovascular events, many countries have issued guidelines concerning their use in treating BPSD.

Methods: We carried out an audit of antipsychotic prescribing practice for inpatients with BPSD at a tertiary referral centre using standards derived from two U.K. dementia guidelines. We collated case note and prescription data and interviewed consultant psychiatrists.

Results: Of the 60 patients with dementia 50 (83%) had BPSD; of these, 28 (56%) were receiving antipsychotics. Those prescribed antipsychotics were more likely to have severe BPSD and to be aggressive and/or agitated. Audit of the 28 patients receiving antipsychotics for BPSD showed generally satisfactory results but there was room for improvement in case note documentation of off-label usage, screening for risk factors of cerebrovascular disease, consultation with relatives and use of an appropriate starting dose and slow titration of the antipsychotic.

Conclusion: Audit of the use of antipsychotics for BPSD is important given the increased mortality associated with their use. Simple audit tools as used in this study can inform clinical practice. Even at a tertiary referral centre prescribing practice could be improved.

Corresponding author
Correspondence should be addressed to: Dr. Camilla Haw, Consultant Psychiatrist, St. Andrew's Hospital, Billing Road, Northampton, NN1 5DG, U.K. Phone: +44 604 616186; Fax: +44 604 616177. Email:
Hide All
Alanen H. M., Finne-Soveri H., Noro A. and Leinonen E. (2006). Use of antipsychotic medications among elderly residents in long-term institutional care: a three-year follow-up. International Journal of Geriatric Psychiatry, 21, 288295.
Ballard C., Waite J. and Birks J. (2006) Atypical antipsychotics for aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD003476. DOI: 10. 1002/14651858. CD003476.pub2.
Bianchetti A., Trabucchi M. and Cipriani G. (2003). Aggressive behavior associated with donepezil treatment: a case report. International Journal of Geriatric Psychiatry, 18, 657658.
Bouman W. P. and Pinner G. (1998). Violent behavior-associated with donepezil. American Journal of Psychiatry, 155, 16261627.
Duff G. (2004). Atypical antipsychotic drugs and stroke: message from Professor Gordon Duff, Chairman, Committee on Safety of Medicines. (CEM/CMO/2004/1) (last accessed 8 January 2008).
FDA Public Health Advisory (2005). Deaths with antipsychotics in elderly patients with behavioral disturbances. (last accessed 8 January 2008).
Gill S. S. et al. (2005). Atypical antipsychotic drugs and risk of ischaemic stroke: population-based retrospective cohort study. BMJ, 330, 445450.
Greve M. and O'Connor D. (2005). A survey of Australian and New Zealand old age psychiatrists' preferred medications to treat behavioral and psychological symptoms of dementia (BPSD). International Psychogeriatrics, 17, 195205.
Hagen B., Esther C. A., Ikuta R., Williams R. J., Le Navenec C. L. and Aho M. (2005). Antipsychotic drug use in Canadian long-term care facilities: prevalence, and patterns following resident relocation. International Psychogeriatrics, 17, 179193.
Lyketsos C. G. et al. (2006). Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. American Journal of Geriatric Psychiatry, 14, 561572.
National Collaborating Centre for Mental Health (2007). Dementia: a NICE-SCIE Guideline on supporting people with dementia and their carers in health and social care. National Clinical Practice Guideline no. 42. (last accessed 8 January 2008).
Royal College of Psychiatrists (2005). Atypical antipsychotics and behavioural and psychiatric symptoms of dementia. http// (last accessed 25 August 2007).
Schneider L. S. et al. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 15251538.
Snowdon J., Day S. and Baker W. (2005). Why and how antipsychotic drugs are used in 40 Sydney nursing homes. International Journal of Geriatric Psychiatry, 20, 11461152.
Soyinka A. and Lawley D. (2007). Antipsychotic prescribing for behavioural and psychological symptoms of dementia. Psychiatric Bulletin, 31, 176178.
SPSS Inc. (2006). SPSS Base 14.0 User's Guide. New Jersey: Prentice Hall.
Trifirò G., Verhamme K. M. C., Ziere G., Caputi A. P., Stricker B. H.Ch. and Sturkenboom M. C. J. M. (2007). All-cause mortality associated with atypical and typical antipsychotics in demented outpatients. Pharmacoepidemiology and Drug Safety, 16, 538544.
World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.
Yorston G. and Pinney A. (2000). Chlorpromazine equivalents and percentage of British National Formulary maximum recommended dose in patients receiving high-dose antipsychotics. Psychiatric Bulletin, 24, 130132.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 3
Total number of PDF views: 20 *
Loading metrics...

Abstract views

Total abstract views: 141 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 22nd October 2017. This data will be updated every 24 hours.